Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Research and Innovation Action · Running

More-EUROPA More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making

Coordinator
Academisch Ziekenhuis Groningen, Netherlands
Runs
1 January 2023 to 31 December 2027
Status
Running
EU funding
€7.0m
Total cost
€7.0m
Partners
15 organisations in 7 countries
Type
Research and Innovation Action
Grant agreement
101095479

What the project is doing

In the project's own words, from its summary on CORDIS.

While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world data (RWD) to contribute to the understanding of drug effects is increasingly realized. Evidence, based on RWD – real world evidence (RWE) - can contribute significantly to the evidence to support decision making throughout all phases of (clinical) drug development, as well as improve efficiency in design and conduct of clinical trial programs.

The aim of this project is to develop, implement and establish evidentiary standards and methods to address the data and evidentiary needs of regulatory authorities and HTA bodies towards a more efficient use of RWD for the development, registration and assessment of medicinal products in Europe (More-EUROPA).

Topics

Who is involved

OrganisationCityCountryRole
Academisch Ziekenhuis GroningenGroningenNetherlandsCoordinator
The European Multiple Sclerosis Platform AisblBruxelles / BrusselBelgiumParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Eurordis - Rare Diseases EuropeParisFranceParticipant
QuintenParisFranceParticipant
Quinten HealthParisFranceParticipant
Universite Paris CiteParisFranceParticipant
Universita Cattolica Del Sacro CuoreMilanoItalyParticipant
Critical Path Institute StichtingAmsterdamNetherlandsParticipant
Iqvia Solutions B.v.AmsterdamNetherlandsParticipant
Stichting Dutch Institute for Clinical AuditingLeidenNetherlandsParticipant
Stichting Radboud Universitair Medisch CentrumNijmegenNetherlandsParticipant
Faculdade de Farmácia da Universidade de LisboaLisboaPortugalParticipant
Karolinska InstitutetStockholmSwedenParticipant
Uppsala UniversitetUppsalaSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI